FCS has opened a new state-of-the-art facility at 2824 Enterprise Road, Orange City, FL 32763-8428 to provide comprehensive treatments and a variety of services to adults with cancer, blood disorders and other diseases.
FCS continues to advance the treatment of gastrointestinal and genitourinary cancers, as evidenced by participation at two global gatherings held this month and sponsored by the American Society of Clinical Oncology (ASCO®).
A best practices program developed at Florida Cancer Specialists & Research Institute (FCS) has been shown to improve outcomes for adult patients prescribed selinexor for the treatment of relapsed/refractory multiple myeloma (RRMM).
Senior Vice President & Data Officer Trevor Heritage, PhD will share learnings gained from the statewide practice’s development of an innovative propriety precision oncology platform at the Precision Medicine World Conference (PMWC® 2024) being held this month in Santa Clara, California.
FCS in collaboration with AdventHealth Heart of Florida and Central Florida Cancer Institute, has been granted a three-year accreditation from the National Accreditation Program for Breast Centers (NAPBC), a quality program of the American College of Surgeons (ACS).
FCS Top News Updates
FCS Expands Clinical Team in Lake County, Welcomes Aamir Hussain to Statewide Practice